A study on tachykininergic neurotransmission in the primate central nervous system aimed at developing novel drugs against mood disorders
对灵长类动物中枢神经系统速激神经传递的研究,旨在开发对抗情绪障碍的新药
基本信息
- 批准号:16590208
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Research of tachykinin receptors in the non-human primate brain would be useful for elucidating the role of the tachykinin system in higher functions such as emotion, as well as for developing new drugs against mood disorders. To this end, we performed the following experiments.1. We cloned the genes encoding the NK-1 and NK-3 tachykinin receptors (referred to as rmNK-1 and rmNK-3) from the rhesus monkey brain and examined their pharmacological profiles and regional distributions in the CNS. Ligand binding studies revealed that the affinity of rmNK-1 to substance P (SP) was comparable to that of hNK-1 in cell lines that expressed individual receptors stably. The expression of rmNK-1 was observed in all of the cortical and subcortical regions, including the hippocampus and the amygdala. The putamen contained the most NK-1 mRNA in the brain, with less rmNK-3 mRNA found in the cortex compared to rmNK-1 mRNA. In the monkey hippocampus and amygdala, rmNK-1 mRNA was present at markedly highe … More r concentrations than rmNK-3 mRNA.2. We investigated the applicability of experimental animals, ranging from rodents to primates, to positron emission tomographic (PET) measurements with [^<18>F] fluoroethyl-SPA-RQ, a modification of a recently established radioligand for NK-1 receptors. A pharmacokinetic assay could be performed for a rhesus monkey in an awake condition, which allows the circumvention of influences of anesthesia on SP neurotransmission. Coregistration of PET and magnetic resonance images acquired by small-animal-dedicated devices enabled detailed localization of NK-1 receptors in the gerbil and marmoset brains. The present study also revealed the potentials of SDZ NKT 343 as an antagonist for central NK-1 receptors. In conjunction with additional in vitro and ex vivo autoradiographic observations, our in vivo results have demonstrated a similarity in the binding pattern among the animals examined, justifying cross-species extrapolation of PET findings on the SP-NK-1 pathway. Less
对非人类灵长类动物大脑中速激肽受体的研究将有助于阐明速激肽系统在情感等高级功能中的作用,以及开发治疗情绪障碍的新药。为此,我们进行了以下实验。1.我们从恒河猴脑中克隆了编码NK-1和NK-3速激肽受体(称为rmNK-1和rmNK-3)的基因,并研究了它们的药理学特征和在CNS中的区域分布。配体结合研究表明,在稳定表达单个受体的细胞系中,rmNK-1对P物质(SP)的亲和力与hNK-1相当。rmNK-1的表达在所有的皮质和皮质下区域,包括海马和杏仁核。壳核含有脑中最多的NK-1 mRNA,与rmNK-1 mRNA相比,在皮质中发现较少的rmNK-3 mRNA。在猴海马和杏仁核中,rmNK-1 mRNA的表达水平显著高于对照组。 ...更多信息 r浓度高于rmNK-3 mRNA。我们研究了实验动物(从啮齿动物到灵长类动物)对使用[^<18>F] fluoroethyl-SPA-RQ(最近建立的NK-1受体放射性配体的修饰)进行正电子发射断层扫描(PET)测量的适用性。可以在清醒状态下对恒河猴进行药代动力学测定,这允许规避麻醉对SP神经传递的影响。通过小动物专用设备获得的PET和磁共振图像的配准,可以详细定位沙鼠和绒猴大脑中的NK-1受体。本研究还揭示了SDZ NKT 343作为中枢NK-1受体拮抗剂的潜力。结合额外的体外和离体放射自显影观察,我们的体内结果已经证明了所检查的动物之间的结合模式的相似性,证明了SP-NK-1途径的PET结果的跨物种外推。少
项目成果
期刊论文数量(55)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
AAV1 mediated co-expression on formylglycine-generating enzyme and arylsulfatase A efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy.
AAV1 介导的甲酰甘氨酸生成酶和芳基硫酸酯酶 A 的共表达可有效纠正异染性脑白质营养不良小鼠模型中脑硫脂的储存。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Kurai;T.
- 通讯作者:T.
Locomotor activity correlates with modifications of hippocampal mossy fibre synaptic transmission
- DOI:10.1111/j.1460-9568.2006.05079.x
- 发表时间:2006-10-01
- 期刊:
- 影响因子:3.4
- 作者:Kobayashi, Katsunori;Ikeda, Yumiko;Suzuki, Hidenori
- 通讯作者:Suzuki, Hidenori
Dopamine selectively potentiates hippocamopal mossy fiber to CA3 synaptic transmission.
多巴胺选择性地增强海马苔藓纤维对 CA3 突触的传递。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Kobayashi;K.
- 通讯作者:K.
Effects of mirthful laughter on growth hormone, IGF-1 and substance P in patients with rheumatoid arthritis.
欢笑对类风湿关节炎患者生长激素、IGF-1 和 P 物质的影响。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Ishigami;S.
- 通讯作者:S.
Expression of DDAH1 in chick and rat embryos.
- DOI:10.1016/j.devbrainres.2003.09.021
- 发表时间:2004-02
- 期刊:
- 影响因子:0
- 作者:T. Mishima;T. Hamada;K. Ui-Tei;F. Takahashi;Y. Miyata;J. Imaki;Hidenori Suzuki;K. Yamashita
- 通讯作者:T. Mishima;T. Hamada;K. Ui-Tei;F. Takahashi;Y. Miyata;J. Imaki;Hidenori Suzuki;K. Yamashita
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUZUKI Hidenori其他文献
摘出ラットレンズ核線条体動脈におけるマグネシウムならびにカリウムによそ血管反応性の解析
离体大鼠晶状体核纹状体动脉血管对镁和钾的反应性分析
- DOI:
- 发表时间:
2010 - 期刊:
- 影响因子:0
- 作者:
SANO takanori;ISHIDA Fujimaro;MIURA Yoich;UMEDA Yasuyuki;TANEMURA Hiroshi;SUZUKI Hidenori;SAKAIDA Hiroshi;MATSUSHIMA Satoshi;SIMOSAKA Shinichi;TAKI Waro;堀内哲吉 - 通讯作者:
堀内哲吉
Impact of the strut positions for hemodynamic modifications in cerebral aneurysm - CFD study with virtual intra-cranial stenting models
支柱位置对脑动脉瘤血流动力学改变的影响 - 使用虚拟颅内支架模型进行 CFD 研究
- DOI:
- 发表时间:
2012 - 期刊:
- 影响因子:0
- 作者:
SANO takanori;ISHIDA Fujimaro;MIURA Yoich;UMEDA Yasuyuki;TANEMURA Hiroshi;SUZUKI Hidenori;SAKAIDA Hiroshi;MATSUSHIMA Satoshi;SIMOSAKA Shinichi;TAKI Waro - 通讯作者:
TAKI Waro
SUZUKI Hidenori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUZUKI Hidenori', 18)}}的其他基金
Development of novel therapeutics for intractable neuropathic pain based on target protector RNA modulating HCN channel function
基于靶保护RNA调节HCN通道功能开发顽固性神经病理性疼痛的新疗法
- 批准号:
20K09232 - 财政年份:2020
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Treatment of chronic pain utilizing GABAergic neuron derived from iPS
利用源自 iPS 的 GABA 能神经元治疗慢性疼痛
- 批准号:
17K10932 - 财政年份:2017
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Clarification of mechanisms of aneurysmal growth and rupture by quantification of 3D-domain hemodynamic irregularity
通过量化 3D 域血流动力学不规则性阐明动脉瘤生长和破裂的机制
- 批准号:
17K10825 - 财政年份:2017
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of curative treatment against neuropathic pain through comprehensive functional analysis of human long non-coding RNAs
通过人类长非编码RNA的综合功能分析开发神经性疼痛的治疗方法
- 批准号:
16H05461 - 财政年份:2016
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cure development by FDG-PET/CT and antiagent sensitivity in intractable head and neck squamous cell carcinoma
FDG-PET/CT 治疗进展及顽固性头颈鳞状细胞癌的抗药物敏感性
- 批准号:
16K11253 - 财政年份:2016
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cure development by FDG-PET and antiagent sensitivity in head and neck cancer
FDG-PET 的治愈开发和头颈癌的抗药物敏感性
- 批准号:
24791821 - 财政年份:2012
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Reconstruction of spinal cord function using collagen filaments
利用胶原丝重建脊髓功能
- 批准号:
23791647 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Elucidation of pathogenesis and new treatment for brain injury after subarachnoid hemorrhage
蛛网膜下腔出血后脑损伤发病机制的阐明和新的治疗方法
- 批准号:
22591584 - 财政年份:2010
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research on serotonergic neurons projecting to the prefrontal cortex as a target of drug development against psychiatric disorders
对投射到前额皮质的血清素能神经元作为精神疾病药物开发目标的研究
- 批准号:
22590249 - 财政年份:2010
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cure development of anticancer agent sensitivity and the cancer stem cell in head and neck cancer
头颈癌抗癌药物敏感性和癌症干细胞的治疗发展
- 批准号:
21791660 - 财政年份:2009
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
相似海外基金
NK-1 Receptor Antagonism: A Role in Opioid Use Disorders
NK-1 受体拮抗作用:在阿片类药物使用障碍中的作用
- 批准号:
9005566 - 财政年份:2015
- 资助金额:
$ 2.05万 - 项目类别:
NK-1 Receptor Antagonism: A Role in Opioid Use Disorders
NK-1 受体拮抗作用:在阿片类药物使用障碍中的作用
- 批准号:
9321363 - 财政年份:2015
- 资助金额:
$ 2.05万 - 项目类别:
NK-1 Receptor Antagonism: A Role in Opioid Use Disorders
NK-1 受体拮抗作用:在阿片类药物使用障碍中的作用
- 批准号:
9144362 - 财政年份:2015
- 资助金额:
$ 2.05万 - 项目类别:














{{item.name}}会员




